Using antibodies derived from alpacas, a University of Kentucky research team has developed a tool that could lead to new therapies to stop the growth of several types of cancer.
The inaugural cohort of President Biden’s Cancer Moonshot Scholars includes University of Kentucky Markey Cancer Center researcher Laurie McLouth, Ph.D.
A Markey Cancer Center research team identified an existing cancer drug that shows promise as a treatment for the most common type of non-small cell lung cancer.
A recent study published in The Journal of Rural Health sheds light on Appalachian Kentucky’s alarming cancer burden, revealing striking disparities compared to non-Appalachian Kentucky and the rest of the country.
Over the past decade, Markey's prestigious National Cancer Institute designation, combined with the research opportunities it provides, has been a catalyst for growth.
Markey Research Day is an opportunity for researchers who study any aspect of cancer to share their work and receive feedback from colleagues across campus.
Markey Cancer Center researchers identified a protein that plays an important role in prostate cancer progression as well as resistance to enzalutamide, a common prostate cancer treatment.
A recent University of Kentucky Markey Cancer Center study reveals that having depression before or after a breast cancer diagnosis was associated with a lower likelihood of survival.
The University of Kentucky Markey Cancer Center’s Biospecimen and Translational Pathology Shared Resource Facility (BPTP SRF) was awarded accreditation from the College of American Pathologists (CAP) based on results of a recent on-site inspection.
